Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving Non-Communicable Disease (NCD) care. Involving 22 biopharmaceutical companies, the initiative works with partners such as World Bank Group and the Union for International Cancer Control to help overcome a variety of access barriers to NCD medicines in low-income and lower-middle income countries. Access Accelerated will support multi-stakeholder dialogue and begin on-the-ground work to improve NCD prevention, diagnosis and treatment.
Our Commitment
*This information describes Astellas’ support for the initiative as of January 18th, 2017
